OxyContin & OxyNEO


The parties have reached an agreement to settle multiple proposed class actions commenced across Canada relating to addiction-related harms allegedly caused by the drugs, OxyContin® and OxyNEO®. The settlement agreement is conditional on it being approved by the courts of Ontario, Nova Scotia, Quebec, and Saskatchewan. The settlement agreement can be viewed here

If you have already provided us with your email or mailing address, you will have received (by mail or email) official notice of the national settlement agreement. The notice provides you with a summary of the key terms of the settlement agreement and provides you with information about your rights to opt-out of or object to the settlement. Notice has also been published in newspapers and online. The notice can be viewed here .

Again, and as the notice sets out in further detail, the courts of Ontario, Nova Scotia, Quebec, and Saskatchewan, will have to approve the settlement for the settlement to be final and to have effect. The hearing dates for settlement approval are July 18, 2017 in Ontario, August 1, 2017 in Nova Scotia, August 9, 2017 in Quebec, and August 24, 2017 in Saskatchewan. These dates are listed in the notice.

If the proposed national settlement agreement is approved, a further notice describing the process for submitting claims for compensation will be distributed.

Top Ten Award Canadian Lawyer Magazine Lexpert ranking logo